The experimental antibody drug specified to President Donald Trump is identified as Probably the most promising techniques to preventing severe ailment from a COVID-19 infection. Its maker, Regeneron Prescribed drugs Inc., claimed the organization agreed to provide only one dose, offered by an IV, for Trump at the request of his health practitioner